Cancer vaccines: the next generation of tools to monitor the anticancer immune response.
Nestle
Frank O
FO
Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. frank.nestle@access.unizh.ch
Tonel
Giulia
G
Farkas
Arpad
A
D015415:Biomarkers / Q000032:analysis; D019496:Cancer Vaccines / Q000276:immunology*; D023381:Endpoint Determination; D006801:Humans; D007107:Immune System / Q000502:physiology*; D007118:Immunoassay; D009369:Neoplasms / Q000276:immunology; D011948:Receptors, Antigen, T-Cell / Q000032:analysis*; D014611:Vaccination
D015415:Biomarkers; D019496:Cancer Vaccines; D011948:Receptors, Antigen, T-Cell